NATCO Pharma Ltd. — filings
Every filing on record for this company. Each row opens the document it names.
| Filing | Period | Scope / kind | Filed | Document |
|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Consolidated | — | INDAS_35548_10828_23052018092912_WEB.xml |
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_35549_10830_23052018093228_WEB.xml |
| Results XBRL (NSE) | 2018-06-30 | Consolidated | — | INDAS_38072_32589_08082018060101_WEB.xml |
| Results XBRL (NSE) | 2018-06-30 | Standalone | — | INDAS_38073_32599_08082018060713_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Consolidated | — | INDAS_40405_58358_06112018064125_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_40408_58365_06112018064613_WEB.xml |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_42875_81667_12022019045745_WEB.xml |
| Results XBRL (NSE) | 2018-12-31 | Consolidated | — | INDAS_42879_81677_12022019050226_WEB.xml |
| Results XBRL (NSE) | 2019-03-31 | Standalone | — | INDAS_44916_104678_27052019070352_WEB.xm |
| Results XBRL (NSE) | 2019-03-31 | Consolidated | — | INDAS_44917_104682_27052019071020_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Standalone | — | INDAS_47172_129706_09082019063243_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Consolidated | — | INDAS_47174_129713_09082019063828_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_50001_164868_12112019043841_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_50002_164871_12112019044002_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_53560_219314_12022020051642_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_53564_219333_12022020052039_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_55961_266021_17062020050159_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_55962_266027_17062020050443_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_59973_305793_12082020052510_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_59975_305802_12082020052704_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_64828_360925_12112020060032_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_64835_360946_12112020060620_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_67963_406041_11022021040411_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_67968_406053_11022021040536_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_71423_460430_17062021065546_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_71424_460433_17062021065720_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_75126_504486_12082021051026_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_75131_504508_12082021051902_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_78377_554536_11112021043536_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_78378_554542_11112021043644_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_82962_610386_14022022061850_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_82966_610408_14022022062941_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_86574_668908_31052022120431_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_86575_668913_31052022120640_WEB.xm |
| Results XBRL (NSE) | 2022-06-30 | Consolidated | — | INDAS_642215_2657_09082022175057_WEB.xml |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_642231_2657_09082022175244_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_854058_4998_10112022162327_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_854066_4998_10112022162359_WEB.xml |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_89155_789613_09022023034535.xml |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_89156_789617_09022023034646.xml |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_93382_857038_29052023100443.xml |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_93383_857041_29052023100647.xml |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_95896_912071_09082023050324.xml |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_95897_912078_09082023050559.xml |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_100797_988006_14112023043703.xml |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_100798_988010_14112023043829.xml |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_104159_1055393_14022024052355.xml |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_104162_1055406_14022024052730.xml |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_107331_1140116_27052024050639.xml |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_107333_1140124_27052024050822.xml |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_111402_1221165_12082024040949.xml |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_111405_1221185_12082024041245.xml |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_115095_1305660_12112024034035.xml |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_115097_1305666_12112024034230.xml |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_119894_1379844_12022025044333.xml |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_119898_1379856_12022025044609.xml |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1454901_28052025 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1454905_28052025 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1509408_12082025 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1509409_12082025 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1574886_14112025 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1574887_14112025 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1624147_12022026 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1624148_12022026 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1676118_29052026 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1676129_29052026 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1714409_14082026 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1714414_14082026 |
| Results XBRL (BSE) | 2018-06-30 | Consolidated | 2018-08-08T17:29:29 | Main_Ind_As_524816_88201817288.xml |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-08-08T17:29:29 | Main_Ind_As_524816_882018172919.xml |
| Results XBRL (BSE) | 2018-09-30 | Consolidated | 2018-11-06T18:27:58 | Main_Ind_As_524816_6112018182552.xml |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-11-06T18:27:58 | Main_Ind_As_524816_6112018182740.xml |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-02-12T16:30:23 | Main_Ind_As_524816_1222019162935.xml |
| Results XBRL (BSE) | 2018-12-31 | Consolidated | 2019-02-12T16:30:23 | Main_Ind_As_524816_1222019163127.xml |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-27T16:56:04 | Main_Ind_As_524816_2752019165543.xml |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-27T16:56:04 | Main_Ind_As_524816_2752019165735.xml |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-08-09T18:23:38 | Main_Ind_As_524816_982019182329.xml |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-08-09T18:23:38 | Main_Ind_As_524816_982019182358.xml |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-11-12T16:19:02 | Main_Ind_As_524816_12112019161820.xml |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-11-12T16:19:02 | Main_Ind_As_524816_12112019161942.xml |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-02-12T17:12:37 | Main_Ind_As_524816_1222020171218.xml |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-02-12T17:12:37 | Main_Ind_As_524816_1222020171255.xml |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-06-17T17:10:46 | Main_Ind_As_524816_1762020171017.xml |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-06-17T17:10:46 | Main_Ind_As_524816_1762020171110.xml |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-08-12T17:21:30 | Main_Ind_As_524816_1282020172025.xml |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-08-12T17:21:30 | Main_Ind_As_524816_1282020172119.xml |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-11-12T17:56:18 | Main_Ind_As_524816_12112020175540.xml |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-11-12T17:56:18 | Main_Ind_As_524816_12112020175630.xml |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-11T15:43:53 | Main_Ind_As_524816_1122021154252.xml |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-11T15:43:53 | Main_Ind_As_524816_1122021154330.xml |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-06-17T18:52:28 | Main_Ind_As_524816_1762021184923.xml |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-06-17T18:52:28 | Main_Ind_As_524816_1762021185136.xml |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-08-12T17:07:57 | Main_Ind_As_524816_128202117634.xml |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-08-12T17:07:57 | Main_Ind_As_524816_128202117736.xml |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-11-11T16:34:10 | Main_Ind_As_524816_1111202116327.xml |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-11-11T16:34:10 | Main_Ind_As_524816_11112021163323.xml |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-02-14T18:11:57 | Main_Ind_As_524816_1422022181015.xml |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-02-14T18:11:57 | Main_Ind_As_524816_1422022181134.xml |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-31T16:16:28 | Main_Ind_As_524816_3052022235926.xml |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-31T16:16:28 | Main_Ind_As_524816_31520220051.xml |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-08-10T13:15:40 | Main_Ind_As_524816_98202217428.xml |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-08-10T13:15:40 | Main_Ind_As_524816_982022174312.xml |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-10T18:22:30 | Main_Ind_As_524816_10112022161842.xml |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-10T18:22:30 | Main_Ind_As_524816_1011202216208.xml |
| Annual report | 1997-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-1997.PDF |
| Annual report | 1999-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-1999.PDF |
| Annual report | 2000-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-2000.PDF |
| Annual report | 2002-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-2002.PDF |
| Annual report | 2003-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-2003.PDF |
| Annual report | 2004-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-2004.PDF |
| Annual report | 2005-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-2005.PDF |
| Annual report | 2007-03-31 | grade B | nan | NATCO_PHARMA_LTD-524816-MARCH-2007.PDF |
| Annual report | 2008-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-2008.PDF |
| Annual report | 2009-03-31 | grade A | nan | NATCO_PHARMA_LTD-524816-MARCH-2009.PDF |
| Annual report | 2010-03-31 | grade A | nan | 5248160310.pdf |
| Annual report | 2011-03-31 | grade A | 2011-09-05T00:00:00 | 5248160311.pdf |
| Annual report | 2012-03-31 | grade A | 2012-09-03T00:00:00 | 5248160312.pdf |
| Annual report | 2013-03-31 | grade A | 2014-01-17T00:00:00 | 5248160313.pdf |
| Annual report | 2014-03-31 | grade A | 2014-09-06T00:00:00 | 5248160314.pdf |
| Annual report | 2015-03-31 | grade A | 2015-09-03T00:00:00 | 5248160315.pdf |
| Annual report | 2016-03-31 | grade A | 2016-10-01T00:00:00 | 5248160316.pdf |
| Annual report | 2017-03-31 | grade A | 2017-10-03T00:00:00 | 5248160317.pdf |
| Annual report | 2018-03-31 | grade A | 2018-09-18T00:00:00 | 5248160318.pdf |
| Annual report | 2019-03-31 | grade A | 2019-08-09T00:00:00 | 5248160319.pdf |
| Annual report | 2020-03-31 | grade A | 2020-09-18T00:00:00 | 67194524816.pdf |
| Annual report | 2021-03-31 | grade A | 2021-09-02T00:00:00 | 70606524816.pdf |
| Annual report | 2022-03-31 | grade A | 2022-09-02T00:00:00 | 75411524816.pdf |
| Annual report | 2023-03-31 | grade A | 2023-09-04T20:27:56.493 | 76692336-a42d-46bd-aa85-16fbb9846663.pdf |
| Annual report | 2024-03-31 | grade A | 2024-09-04T18:01:54.19 | d5a992a3-1b5a-44b4-8e5b-343b600e56fc.pdf |
| Annual report | 2025-03-31 | grade A | 2025-08-29T18:10:46.593 | 08737473-9fef-496b-881b-746b8ab600b1.pdf |
| Annual report | 2026-03-31 | grade A | 2026-09-04T20:11:52.41 | 0d25dc00-4a7e-4acc-b5a8-d747c870ab2f.pdf |
| Concall | 2021-06-30 | TRANSCRIPT | — | Date_20220817_NATCO Pharma Ltd._Concal_Q1FY22.pdf |
| Concall | 2022-03-31 | COVER_LETTER | — | Date_20220531_NATCO Pharma Ltd._Concal_Q4FY22.pdf |
| Concall | 2022-03-31 | TRANSCRIPT | — | Date_20220604_NATCO Pharma Ltd._Concal_Q4FY22.pdf |
| Concall | 2022-06-30 | COVER_LETTER | — | Date_20220810_NATCO Pharma Ltd._Concal_Q1FY23_Audio.pdf |
| Concall | 2022-09-30 | COVER_LETTER | — | Date_20221111_NATCO Pharma Ltd._Concal_Q2FY23_Audio.pdf |
| Concall | 2022-12-31 | COVER_LETTER | — | Date_20230210_NATCO Pharma Ltd._Concal_Q3FY23_Audio.pdf |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230213_NATCO Pharma Ltd._Concal_Q3FY23.pdf |
| Concall | 2023-03-31 | COVER_LETTER | — | Date_20230530_NATCO Pharma Ltd._Concal_Q4FY23_Audio.pdf |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230601_NATCO Pharma Ltd._Concal_Q4FY23.pdf |
| Concall | 2023-06-30 | COVER_LETTER | — | Date_20230810_NATCO Pharma Ltd._Concal_Q1FY24_Audio.pdf |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230814_NATCO Pharma Ltd._Concal_Q1FY24.pdf |
| Concall | 2023-12-31 | TRANSCRIPT | — | Date_20240221_NATCO Pharma Ltd._Concal_Q3FY24.pdf |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20240604_NATCO Pharma Ltd._Concal_Q4FY24.pdf |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20250604_NATCO Pharma Ltd._Concal_Q4FY24.pdf |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20240813_NATCO Pharma Ltd._Concal_Q1FY25.pdf |
| Concall | 2024-06-30 | COVER_LETTER | — | Date_20240813_NATCO Pharma Ltd._Concal_Q1FY25_Audio.pdf |
| Concall | 2024-06-30 | DUPLICATE | — | Date_20240813_NATCO Pharma Ltd._Notice_Notice.pdf |
| Concall | 2024-06-30 | DUPLICATE | — | Date_20240821_NATCO Pharma Ltd._Concal_Q1FY25.pdf |
| Concall | 2024-06-30 | DUPLICATE | — | Date_20240821_NATCO Pharma Ltd._Concal_Q1FY25_v2.pdf |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20250819_NATCO Pharma Ltd._Concal_Q1FY25.pdf |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241121_NATCO Pharma Ltd._Concal_Q2FY25.pdf |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20251115_NATCO Pharma Ltd._Concal_Q2FY25.pdf |
| Concall | 2024-09-30 | COVER_LETTER | — | Date_20251115_NATCO Pharma Ltd._Notice_Q2FY25.pdf |
| Concall | 2024-12-31 | TRANSCRIPT | — | Date_20250219_NATCO Pharma Ltd._Concal_Q3FY25.pdf |
| Concall | 2025-06-30 | ANALYST_MEET | — | Date_20250724_NATCO Pharma Ltd._Concal_Recovered.pdf |
| Concall | 2025-06-30 | COVER_LETTER | — | Date_20250724_NATCO Pharma Ltd._Notice_Notice.pdf |
| Concall | 2025-06-30 | DUPLICATE | — | Date_20250729_NATCO Pharma Ltd._Concal_Q1FY26.pdf |
| Concall | 2025-06-30 | COVER_LETTER | — | Date_20260814_NATCO Pharma Ltd._Concal_Q1FY26.pdf |
| Concall | 2025-06-30 | DUPLICATE | — | Date_20260818_NATCO Pharma Ltd._Concal_Q1FY26.pdf |
| Concall | 2025-09-30 | DUPLICATE | — | Date_20251120_NATCO Pharma Ltd._Concal_Q2FY26.pdf |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260604_NATCO Pharma Ltd._Concal_Q4FY26.pdf |
| Concall | 2026-03-31 | DUPLICATE | — | Date_20260604_NATCO Pharma Ltd._Concal_Q4FY26_v2.pdf |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260814_NATCO Pharma Ltd._Concal_Q1FY27.pdf |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161086_525495_08102021042704_WEB.xml |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_164223_584426_12012022024041_WEB.xml |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_166822_633937_13042022042151_WEB.xml |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169732_692034_18072022094328_WEB.xml |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_171233_727525_15102022121834_WEB.xml |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_173637_759897_10012023120526_WEB.xml |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176015_812434_10042023025736_WEB.xml |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_178741_882375_13072023115048_WEB.xml |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_180930_945361_10102023041159_WEB.xml |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183362_1010369_08012024031312_WEB.xm |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_186509_1089824_12042024050213_WEB.xm |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_188978_1178430_10072024044528_WEB.xm |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_191820_1267923_14102024024421_WEB.xm |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_193987_1398143_20032025025533_WEB.xm |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197335_1415362_16042025104507_WEB.xm |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1482950_15072025022733_WEB.xml |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1543722_09102025062609_WEB.xml |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1603978_19012026020157_WEB.xml |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1647709_09042026102912_WEB.xml |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1689944_09072026054425_WEB.xml |
| Related-party XBRL | 2022-09-30 | — | — | RPT_NATCOPHARM_22112022162058.xml |
| Related-party XBRL | 2023-03-31 | — | — | RPT_856234_29052023041949_WEB.xml |
| Related-party XBRL | 2023-09-30 | — | — | RPT_988013_14112023044009_WEB.xml |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1140226_27052024053539_WEB.xml |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1305948_12112024044055_WEB.xml |